HB 1290-FN (2022): establishing a task force on precision medicine and biomarker testing.
Cite this page
Granite Record indexes the General Court’s record; it is not that record. Where a citation allows only one source, cite the General Court — every page here links to what it is drawn from. The date below is the day the page was read.
- MLA
- “HB 1290-FN (2022): establishing a task force on precision medicine and biomarker testing.” Granite Record, https://graniterecord.org/bill/2022/hb1290. Accessed 24 Oct. 2026.
- APA
- Granite Record. (n.d.). HB 1290-FN (2022): establishing a task force on precision medicine and biomarker testing. Retrieved 24 Oct. 2026, from https://graniterecord.org/bill/2022/hb1290
- Chicago
- Granite Record. “HB 1290-FN (2022): establishing a task force on precision medicine and biomarker testing.” Accessed 24 Oct. 2026. https://graniterecord.org/bill/2022/hb1290.
- BibTeX
@misc{bill-2022-hb1290, title = {HB 1290-FN (2022): establishing a task force on precision medicine and biomarker testing.}, howpublished = {Granite Record}, url = {https://graniterecord.org/bill/2022/hb1290}, note = {Accessed 24 Oct. 2026} }
HB 1290-FN (2022)
establishing a task force on precision medicine and biomarker testing.
- Status: Referred for interim study
- Term: 2021-2022
- House committee: Health, Human Services and Elderly Affairs
- Subject: Miscellaneous
The Story
It was introduced on January 5, 2022 and referred to the House Health, Human Services and Elderly Affairs committee. The committee held a public hearing on February 15, 2022. The committee met in executive session on March 8, 2022 to vote on its recommendation. The committee voted unanimously, 20–0, to recommend that the House study it after the session ends, and the report was placed on the consent calendar. On March 15, 2022 the House voted to study it after the session ends on a voice vote. The committee held a work session on June 6, 2022. The committee reported back on its interim study of the bill: “Not Recommended for Future Legislation”, by a vote of 17 to 0.
Sponsors
- Rep. Katherine Rogers (D - Merr 28) (prime sponsor)
Hearings and Sessions
- February 15, 2022, 9:30 AM: public hearing, House Health, Human Services and Elderly Affairs, LOB 210-211
- March 8, 2022, 9:30 AM: executive session, House Health, Human Services and Elderly Affairs, LOB 210-211
- June 6, 2022, 9:30 AM: work session, House Health, Human Services and Elderly Affairs, LOB 201-203
Votes
- March 15, 2022, House: Refer for Interim Study — voice vote, passed
The Docket
- January 5, 2022: Introduced 01/05/2022 and referred to Health, Human Services and Elderly Affairs
- February 15, 2022: Public Hearing: 02/15/2022 09:30 am LOB 210-211
- March 8, 2022: Executive Session: 03/08/2022 09:30 am LOB 210-211
- March 9, 2022: Committee Report: Refer for Interim Study (Vote 20-0; CC)
- March 15, 2022: Refer for Interim Study: MA VV 03/15/2022
- June 6, 2022: Interim Study Work Session: 06/06/2022 09:30 am LOB 201-203
- October 19, 2022: Interim Study Report: Not Recommended for Future Legislation (Vote 17-0)